Federal grants to Pai Life Sciences Inc
Pai Life Sciences Inc in Seattle, Washington received $5.4 million in federal grants from fiscal 2021 to 2025, across 6 awards. Its largest program was Allergy and Infectious Diseases Research, with $5.1 million. In fiscal 2025 it was awarded $452,996.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$5.4 million
- Awards6
- Awarded in FY 2025$452,996
- Largest award$3.4 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 4 | $1.8 million |
| FY 2022 | 2 | $1.5 million |
| FY 2023 | 1 | $295,653 |
| FY 2024 | 2 | $1.3 million |
| FY 2025 | 1 | $452,996 |
Programs that fund Pai Life Sciences Inc
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 5 | $5.1 million |
| Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases | 1 | $243,000 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 6 | $5.4 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| A vaccine for lymphatic filariasis, lfguard? | Allergy and Infectious Diseases Research | May 21, 2021 | $3.4 million |
| A vaccine for schistosomiasis, "schistoshield" | Allergy and Infectious Diseases Research | February 4, 2021 | $1.0 million |
| Evaluation of a next generation schistoshield vaccine - abstract schistosomiasis is a major parasitic disease which could impact one billion people with 252 million currently infected and 779 million at risk to acquire the infection in 74 countries. Current control strategies have relied on repeated | Allergy and Infectious Diseases Research | September 12, 2023 | $300,000 |
| Antigen and adjuvant selection for a vaccine against urogenital schistosomiasis, hematoshield - project summary schistosomiasis, caused by parasitic helminths, remains a major global health problem currently affecting over 250 million people in 78 countries with an additional 800 million people at r | Allergy and Infectious Diseases Research | January 3, 2024 | $295,386 |
| Adjuvanted recombinant candidates to prime / boost COVID-19 rna vaccines | Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases | September 8, 2021 | $243,000 |
| Developing a screen for new adjuvants to enhance rna vaccines | Allergy and Infectious Diseases Research | April 23, 2021 | $59,861 |
Questions people ask
How much federal grant money does Pai Life Sciences Inc get?
$5.4 million in 6 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Pai Life Sciences Inc the most?
The Department of Health and Human Services, with $5.4 million in 6 awards.
What is Pai Life Sciences Inc's largest federal grant?
$3.4 million under Allergy and Infectious Diseases Research, with its first action in the period on May 21, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Pai Life Sciences Inc?
Its largest are Allergy and Infectious Diseases Research and Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases.
Other grant recipients in Seattle
- University of Washington
- Central Puget Sound Regional Transit Authority
- Fred Hutchinson Cancer Center
- King County Metro Transit
- Port of Seattle
- Seattle Children's Hospital
- Allen Institute
- Seattle Housing Authority
Largest federal grant recipients in Washington · Federal grants in Washington